Endurant Capital Management LP Ocular Therapeutix, Inc Transaction History

Endurant Capital Management LP

$0
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $663,807 - $1.1 Million	-144,306 Reduced 28.14%	368,438 $1.9 Million
Q1 2023 May 15, 2023	SELL	$2.79 - $6.27 $1.54 Million - $3.46 Million	-551,209 Reduced 51.81%	512,744 $2.7 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $892 - $1,508	-342 Reduced 0.03%	1,063,953 $2.99 Million
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $1.24 Million - $1.98 Million	304,067 Added 40.0%	1,064,295 $4.42 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $492,842 - $854,696	-163,735 Reduced 17.72%	760,228 $3.06 Million

Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $998,940 - $1.52 Million	206,820 Added 28.84%	923,963 $4.57 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $657,530 - $1.29 Million	106,742 Added 17.49%	717,143 $5 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $382,480 - $565,440	39,431 Added 6.91%	610,401 $6.1 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $1.77 Million - $2.53 Million	132,037 Added 30.08%	570,970 $8.1 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $2.35 Million - $3.28 Million	148,468 Added 51.11%	438,933 $7.2 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $4.32 Million - $12.5 Million	-546,672 Reduced 65.3%	290,465 $6.01 Million
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $602,099 - $807,435	81,807 Added 10.83%	837,137 $6.37 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $3.53 Million - $6.76 Million	755,330 New	755,330 $6.29 Million
Q2 2019 Aug 14, 2019	SELL	$2.46 - $4.52 $1.76 Million - $3.24 Million	-716,124 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.51 - $4.77 $1.7 Million - $2.31 Million	483,397 Added 207.71%	716,124 $2.84 Million
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $268,678 - $493,618	-69,426 Reduced 22.98%	232,727 $926,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $863,828 - $1.11 Million	159,378 Added 111.63%	302,153 $2.08 Million
Q2 2018 Aug 14, 2018	SELL	$5.99 - $8.17 $213,759 - $291,554	-35,686 Reduced 20.0%	142,775 $964,000
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $831,628 - $1.26 Million	178,461 New	178,461 $1.16 Million

Others Institutions Holding OCUL

# of Institutions

148

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account